Clinical Trial

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis

Name: A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis — clinical trial record (NCT06767540)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a randomized double-blind, placebo-controlled, multicenter phase III clinical study evaluating the efficacy and safety of AK120 in the treatment of moderate-to-severe AD in adolescents.

Trial Details

NCT Number	NCT06767540
Lead Sponsor	Akeso
Conditions	Atopic Dermatitis
Enrollment	198 participants
Start Date	2025-01-23
Primary Completion	2027-07-10 (estimated)
Study Completion	2027-07-10 (estimated)
Updated on ClinicalTrials.gov	2025-01-10